Skip to content

Kasios Biomaterials

Country not established

Devices
1

What Kasios Biomaterials makes

Kasios Biomaterials manufactures the KASIOS TCP, a tissue-engineered product designed for soft tissue repair and regeneration, intended for surgical applications.

The company’s portfolio is regulated under FDA’s Class II device classification, with the KASIOS TCP authorised via the 510(k) pathway. The product is listed in the FDA’s 510(k) database. Kasios Biomaterials is headquartered in the United States.

AI-generated from registry data, 2 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue1

Newest first, rows 1-1 of 1

  • Kasios Tcp Ref K042340

    Active Regimes: 510(k) Registry: 510(k) Class:II

Frequently asked questions

How many devices does Kasios Biomaterials have in the registry?

The registry currently lists 1 device for Kasios Biomaterials. Devices recorded under merged duplicate company entries are counted once.

Which registries list Kasios Biomaterials's devices?

Among its 1 most recently registered device, Kasios Biomaterials has devices listed in FDA 510(k) (1 device).

What risk classes do Kasios Biomaterials's devices fall under?

Among its 1 most recently registered device, the classes recorded for Kasios Biomaterials's devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Kasios Biomaterials in the registry?

The most recently registered devices listed for Kasios Biomaterials include KASIOS TCP.

Generated automatically from registry data and not verified by a human reviewer.